In an interview with Biotech & Money / LSX – The Network For Life Science Executives, our partner, Uffe Boesen, […]
We are delighted that the leading Danish business newspaper Børsen has named Xplico a 2017 Gazelle Company for the 2nd […]
Golnaz has 10+ years’ experience in biotech and medtech research and industry. She holds a PhD in Analytical Biotechnology from […]
We are delighted that the leading Danish business newspaper Børsen has named Xplico a 2016 Gazelle Company. Børsen analyses every […]
Xplico is pleased to announce that Peter Abelin has joined our valuation team.
Peter has more than 25 years’ experience […]
Xplico Captable is a capitalization table providing simulations and waterfall analysis of the founders’ and investors’ percentage of ownership, equity […]
We are pleased to announce that we have released the first version of the Xplico Evaluator consolidation module Xplico Consolidation. […]